8-K Announcements
6Material company update
May 11, 2026·SEC
Material company update
Mar 24, 2026·SEC
Material company update
Mar 2, 2026·SEC
Sanara MedTech Inc.(SMTI)Earnings, Financials & Key Ratios
SMTI•NASDAQ
$25.17
Price updated Jul 6, 2026
AboutSanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako's Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako's Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako's Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.Show more
- Revenue$103M+19.0%
- EBITDA$12M+758.8%
- Net Income-$38M-288.7%
- EPS (Diluted)-4.36-282.5%
- Gross Margin90.13%-0.5%
- EBITDA Margin11.45%+653.8%
- Operating Margin8.87%+214.5%
- Net Margin-36.43%-226.7%
- ROE-167.53%-623.7%
SMTI Price & Volume
Sanara MedTech Inc. (SMTI) stock price & volume — 10-year historical chart
Loading chart...
SMTI Growth Metrics
Sanara MedTech Inc. (SMTI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years40.78%
5 Years45.92%
3 Years31.03%
TTM17.41%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-193.85%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-190.97%
Return on Capital
10 Years-27.9%
5 Years-15.12%
3 Years-1.17%
Last Year14.39%
SMTI Recent Earnings
Sanara MedTech Inc. (SMTI) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 11, 2026Metric
Actual
Est
EPS
$0.04+200.0%
$0.04
Rev
$28M+3.7%
$27M
Q2 2026
Mar 24, 2026Metric
Actual
Est
EPS
$0.04-63.6%
$0.11
Rev
$28M+0.5%
$27M
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$0.09+137.5%
$0.24
Rev
$26M-3.2%
$27M
Q3 2025
Aug 13, 2025Metric
Actual
Est
EPS
$0.23+30.3%
$0.33
Rev
$26M-2.9%
$27M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 11, 2026 | $0.04vs $0.04+200.0% | $28Mvs $27M+3.7% |
| Q2 2026 | Mar 24, 2026 | $0.04vs $0.11-63.6% | $28Mvs $27M+0.5% |
| Q4 2025 | Nov 12, 2025 | $0.09vs $0.24+137.5% | $26Mvs $27M-3.2% |
| Q3 2025 | Aug 13, 2025 | $0.23vs $0.33+30.3% | $26Mvs $27M-2.9% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Sanara MedTech Inc. (SMTI)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $25.17 | $230.66M | -5.77 | 18.97% | -36.43% | -167.53% | — | |
| $17.32 | $1.97B | -14.20 | 8.28% | -25.66% | -50.82% | — | |
| $0.42 | $58.49M | 13.90 | 14.21% | 1.5% | 3.68% | — | |
| $4.07 | $604.67M | 12.72 | 19.99% | 7.88% | 12.86% | — | |
| $11.03 | $352.94M | 4.80 | 6774.96% | -256.6% | -17.04% | — | |
| $17.11 | $6.1B | -16.77 | 6.47% | -4.21% | -3.37% | — |
Compare SMTI vs Peers
Sanara MedTech Inc. (SMTI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SMTI SEC Filings & Documents
Sanara MedTech Inc. (SMTI) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when SMTI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SMTI Frequently Asked Questions
Sanara MedTech Inc. (SMTI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Sanara MedTech Inc.'s revenue?
Sanara MedTech Inc. (SMTI) reported $107.5M in revenue for fiscal year 2025. This represents a 4677% increase from $2.3M in 1999.
How fast is Sanara MedTech Inc. growing?
Sanara MedTech Inc. (SMTI) grew revenue by 19.0% over the past year. This is strong growth.
Is SMTI profitable?
Sanara MedTech Inc. (SMTI) reported a net loss of $33.6M for fiscal year 2025.
Dividend & Returns
What is SMTI's return on equity?
Sanara MedTech Inc. (SMTI) has a return on equity (ROE) of -167.5%. Negative ROE indicates the company is unprofitable.
What is Sanara MedTech Inc.'s free cash flow?
Sanara MedTech Inc. (SMTI) generated $3.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.